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Rat Monoclonal Antitubulin Antibodies Derived by
Using a New Nonsecreting Rat Cell Line
Antibodies to tubulin play an important role in investigating
the structure and function ofmicrotubules in cells. For instance,
immunofluorescence with antitubuhn antibodies has shown
that, in addition to their role in the mitotic spindle, microtu-
bules are a basic component of the cytoskeleton of the inter-
phase cell and are long structures extending from the centros-
pherejust outside the nucleus to the plasma membrane (25). In
addition, immunofluorescence is a rapid method for checking
the response of microtubules in lysed cell models to various
stimuli, such as drugs (34) or calcium ions (30).
The structural information from immunofluorescence has
been extended further by electron microscopy, either directly
in negatively stained whole mounts (26, 35) or indirectly in
thin sections after labeling second antibodies with peroxidase
(7, 8) or gold particles (9) . Radioimmune assays of amounts of
tubulin in cells have been useful in, for example, determining
whether formation of microtubules in neuroblastoma cells
during neurite extension occurs as a response to tubulin syn-
thesis, or activation of a pre-existing tubulin pool (16) . Anti-
bodies can be made specific for the a or /3 subunits of tubulin,
and used to identify these subunits in SDS gels (31) . The use
of these antitubulin antibodies could be extended further to
purify microtubule-containing organelles .
Unfortunately, tubulin is usually a poor antigen even after
repeated doses and, apart from a few exceptional cases (20, 33),
the antisera have low titers, in the region of 1:200 (1, 15, 22,
23), indicating a combination of low affinity and low concen-
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ABSTRACT
￿
Hybrid myeloma cell lines secreting monoclonal antibodies to tubulin have been
prepared using rat myelomas and spleen cells from rats immunized with yeast tubulin . A
comparison between the results obtained with the rat myeloma Y3-Ag 1 .2.3 ., which secretes a
light chain, and a new line, YB2/O, which does not, shows that they are both excellent parental
lines and that the second produces hybrids with no myeloma chain components .
The antitubulin antibodies in the serum of rats bearing two of the hybrid myeloma tumors
gave titers of up to 1 :106 from which large amounts of monoclonal antibodies could be easily
purified . They recognized tubulin from yeast as well as from birds and mammals . The two
antibodies gave clear immunofluorescent staining of yeast mitotic spindles as well as the
interphase microtubule network of tissue culture cells. Some difference in the pattern of
immunofluorescence staining of yeast cells and nuclei was observed between the two anti-
bodies . The purified antibodies could be conjugated to colloidal gold particles and used for
direct labeling of yeast microtubules for electron microscopy .
tration of antibodies . Affinity purification of the antibody (12)
yields only 0 .1 mg/75 ml serum (I1) or 0.1-1 mg/10 ml serum
(2), adequate for indirect immunofluorescence but insufficient
for preparative work. A solution to this problem is to derive
hybrid myeloma lines (19) secreting appropriate antibodies
against tubulin in order to prepare monoclonal antibodies in
unlimited quantities . In addition to their preparative uses, such
antibodies used either singly or in mixtures would be more
convenient reagents for immunofluorescence than the mono-
specific antisera currently available in some laboratories.
Since the antitubulin monoclonal antibodies are ultimately
to be used for preparative purposes, hybrids between rat cells
and a rat myeloma rather than mouse x mouse hybrids is a
better choice because of the larger volume of serum and ascitic
fluid of tumor-bearing animals .
At present, the rat myeloma Y3-Ag 1.2.3 . is being used in
such fusions (13). This line is very suitable but has the disad-
vantage of secreting a light chain. The hybrids express both
the antibody and the myeloma light chain, giving rise to what
we refer to asHLK antibodies. These are mixtures of molecules
containing the myeloma (K) and antibody (L) light chains in
different combinations, namely H2L2, H 2K2 (usually inactive)
and LH 2K (usually monovalent) (6, 19) .
To avoid this complication, a nonsecreting rat myeloma
(YB2/O) was prepared, and its derivationanduse are described
here. Hybrids secreting antitubulin antibody were prepared
using both myeloma lines Y3-Ag 1.2.3 . and YB2/O . Both
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clonal antibodies. As expected, the hybrids produced by YB2/
O did not express the myeloma light chain .
MATERIALS AND METHODS
Tissue Culture
Dulbecco's modified Eagle's medium (DME) (Gibco-Biocult, Glasgow, Scot-
land) was supplemented with sodium pyruvate and penicillin/streptomycin. The
batches of fetal calf serum (FCS) (Sera Lab., Crawley Down, England) were
selected to sustain best growth at limiting cell dilution in the absence of feeder
cells. The atmospheric environmentwas 10%COr air, andtheNaHCOa content
adjusted accordingly. Radioactive cultures for the chemical identification of
immunoglobulin chains were prepared as described in Galfre and Milstein (14) .
Derivation of the Rat Myeloma Cell Line YB2/O
This is a derivative of the hybrid myeloma YB2/3HL (21) . The cells, grown
in DME with 10% FCS, were cloned in soft agar. Clones were isolated and
treated for the production of rat Ig by indirect agglutination of sheep red blood
cells which had been CrCla-coupled to sheep anti-rat Ig (14) . From 116 clones
tested, three were selected as being negative or weak positives.
Immunoglobulin synthesis in either the secreted or intracellular fractions was
investigated by ["C]lysine incorporation followed by SDS gel electrophoresis of
the spent medium (for secreted Ig) and of the sheep anti-rat immunoglobulin
precipitable materialin total celllysates(for intracellular Ig). One clonecontained
both heavy and light chains intracellularly but seemed to have lost the capacity
to secrete the Ig. The second synthesized and secreted light chains only, and the
third did not secrete but synthesized heavy chains . This third clone was selected
and 43 subclones were isolated . The presence of intracellular heavy chains was
tested by fluorescence microscopy, using rabbit FITC-anti-rat-Ig. It was found
that the majority of the subclones (21) were negative, nine were positives, and 12
were either mixed clones or uncertain. The negative clones were further checked
for their growth characteristics, and for absence of intracellular Ig chains, by
["C]lysine intracellular incorporation into antibody-precipitable material. After
further subclonings including an azaguanine resistant step, the clone YB2/
3HL.P2.G11 .16Ag.20 was selected. This will be,referred to as YB2/O. It dies
within 3 d inHATmedium, and, before use, it was adapted to grow in 2.5% fetal
calf serum . Cloning and other experimental procedures were carried out as
described in (14).
The line YB2/O is a nonproducer variant of a hybrid myeloma originating
from a fusion betweenAO cells andLOU cells. Tumors are grown in (LOU x
AO)F, hybrids . When injected into LOU inbred strain animals, tumors are
sometimes rejected . Recently, we have been able to adapt the tumor by serial
passage into animals, and aderivative called YBOhas beenprepared (C. Milstem
and B . Wright, unpublished results) which is not rejected by LOU rats . It
suitability for the derivation ofhybrid myelomas is being tested.
Immunization Schedule
Two LOU rats (originally obtained from the Institute of Cancer, Catholic
University, Louvain, Belgium) were injected intraperitoneally with 201ag ofyeast
tubufin (5 mg/ml in 0.1 MPIPESpH 6.9,0.1 mM MgCl2, 1 mM GTP) purified
by one cycle ofassembly-disassembly (18) emulsified in Freud's complete adju-
vant. They were boosted with similar doses in incomplete adjuvant at days 22
and 53 . At day 29 the titer oftheantiserum determined by the solid phaseindirect
binding assay was measured and the rat giving the better apparent serum titer of
about 1 :1,000 was given an intravenous dose of20Iug yeast tubufin at day 89 and
used for the fusion experiment.
Fusion and Derivation of Hybrids
4 d after the intravenous injection of yeast tubufin, the hyperimmunized rat
was sacrificed and the spleen removed . Preparation of spleen cells and the
protocol for fusion were as described by Galfre and Milstein (14). Themyeloma
cells were taken from steady-state growing spinner cultures, and this seems quite
important for good yields of hybrids. Twoindependent fusions with 108 spleen
cells each, and with 6 x 10' each ofYB2/O andY3/Ag 1 .2 .3 . were prepared in
parallel. Each fused population was distributed in 2-ml well Linbro plates (Flow
Laboratories, Ltd., Irvine, Scotland) containing a feeder layer of irradiated 3T3
fibroblasts as follows: 36 wells, each containing 1/50th ofthe total fused cells, 12
wells each containing 1/100th, 12 wells with 1/200th, and 36 wells with 1/400th
of the total fused cells . After 24 hof culture in DMEcontaining 2090 of FCS,
one-half of the medium was replaced with medium containing hypoxanthine,
aminopterine, and thymidine . The operation was repeated on the two subsequent
days, and then every 2 d . After -20 d, the presence ofantibody to tubufin was
tested by the binding assay described below.
Binding Assay
25 lal ofyeast or chick brain tubulin (50 ILg/ml in 0.1 M PIPES, pH 6.9,0.1
mM MgCl,, l mM GTP) was added to each well of a 96-well microtiter plate
(Sterilin Ltd., Teddington, England), and left overnight at 4°C. Chick brain
tubufin was prepared as described by Dender et al. (10) and purified on aDEAE
Sephadex A-50 column (24) . The tubulinwasremoved fromthe wellandreplaced
by 100 pl 10 mg/ml bovine serum albumin (Armour, Eastbourne, England), 0.05
Msodium phosphate, pH 7.4, 0.15M NaCl, 1 mg/mlNaNa (BSA-PBS), and the
plate was left at room temperature for 1h . The wells were washedtwice with 100
lrl of BSA-PBS, and 25 lrl of cell supernatant orantiserum wasadded and left for
1 h at 4°C . The wells were again washed twice with 1001Al of BSA-PBS, and 25
ld of -100,000 cpmof 1'25-(Fab)2 sheep anti-rat Ig (36) in BSA-PBS wasadded .
The sheep anti-rat Ig antibody was purified by affinity chromatography of
antiserum from a sheep immunized with rat IgG, the absorbent was the ratIgG2
myeloma protein 5208 (28). The wells were washed four times with 100 Id of
BSA-PBS, and the bound I" counts were eluted with 2N NaOH and counted in
ay counter .
Fluorescence Microscopy
Yeast spheroplasts were prepared by digestion of log phase Saccharomyces
uvarum (NCYC 74) with 1.2 mg/ml mutanase (Novo, Windsor, England) and
0.6 mg/ml Zymolyase 5000 (Miles Laboratories, Slough, England) in 1.1 M
sorbitol at 108 cells/ml for 2 h at 30°C . Yeast nuclei were prepared as described
by Rozijn and Tonino (29) . CHO-K, and3T3 cells were incubated on an 8-well
Flow Laboratories slide at 37°C overnight, and fixed in glutaraldehyde/NaM
(8, 35) or in McOH for 6 minand acetone for 30 s at -20°C . Yeast spheroplasts
and nucleiwere placed inan 8-well slide coated with 1 mg/ml polylysine (400,000
mol wt; Sigma Chemical Co., St . Louis, MO), and fixed for 10 min at room
temperature with 3.7% formaldehyde or 1% glutaraldehyde in 1 .1 M sorbitol for
spheroplasts or, for nuclei, in 1.8Msucrose nuclear buffer (29) . Thiswas followed
by fixation in McOH and acetone or NaBH, treatment as above. Antibody was
added for I h at 20°C, then the wells were washed three times with BSA-PBS,
and second antibody was then added . This was for nuclei FITC-anti rat IgG
(Miles, Slough, England) and for cells the same antiserum purified by affinity
chromatography on Sepharose 4B coupled with YLl/2 IgG. After 1 h at 20°C
the wells were washed three times with BSA-PBS and mounted in 90% glycerol.
Slides were observed by epifluorescence using a Zeiss standardWL microscope
equipped with a HBO 50 W high pressure Hg lamp.
Cloning of Hybrids
Cloningwas attempted starting-I mo after fusion . Plates containing 10,000,
3,000, 1,000, and 300 cellswere seeded on semi-solid agar in the absence of feeder
cells as described by Galfre and Milstein (14) . Clones were picked when they
were of -100-500 cells and transferred to 2-ml culture wells. When the micro-
culture was nearly confluent, the presence ofantitubulin antibody was tested by
the binding assay. Clones retained were the positive ones which originated from
agar dishes with the lowest density. When positive cultures were from high
density plates, the picked material ("agar plugs") may contain multiple clones.
The step was not considered a cloning step, but ifthe cultures were positive they
were retained as better adapted for cloning.
The most valuable clones were subcloned once again before final selection of
a permanent stock clone. Frozen sampleswere prepared at different stages by the
usual method (14) .
Large-scale Preparation of Monoclonal Antibody
Large quantities of monoclonal antibody were prepared by growing tumours
in rats by subcutaneous injection of 5 x 10' cells of the selected hybrid clone .
Serum from the animal which was killed was used to purify IgG. The Y3/Ag
1.2 .3 . myeloma is ofLOU origin and the spleen wasfrom aLOU rat. Tumors
from them were usually grown in inbredLOU rats.
Since YB2/O is itself a hybrid originating from a fusion between LOU
myeloma (Y3/Ag 1.2.3 .) and AO spleen cells, tumors derived from theYB2/O
fusion were grown in (LOU x AO) F, hybrids . We have observed that hybrid
myelomas prepared with YB2/Ocan be adapted to grow inLOU rats .
In some experiments, tumors were grown ascitic, by intraperitoneal injection
of 5 x 10' cells into rats which 2wk previously had been injected with 0.5 ml of
pristane .
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YLI/2 or YOLI/34 IgG was precipitated from serum or ascites by 50%
ammonium sulphate, and, after dialysis against 0.01M sodium phosphate, pH
7.0, was collected as the breakthrough peak after chromatography on DE-52
(Whatman Ltd., Maidenhead, England) equilibrated with the same buffer. The
yield of IgG was 10 mg/ml serum.
Conjugation of IgGs to 200 Á Colloidal
Gold Particles
YOLI/34 andYL1/2 IgGs were conjugated to 200 .$ colloidal gold particles
at pH 9.0, as described by De May et al. (9), except that 10 mg/ml BSA adjusted
to pH 7.0 with NaOH wasadded 2min aftertheIgG followed by 0.15MNaCl.
The antibodies conjugated to the 200A colloidal gold particles did not penetrate
the intact nuclei, so nuclei were lysed in 0.1 MM MgC12 and separated on a
sucrose gradient at 180,000g for 90 min at 4°C . The gradient consisted ofequal
volumes of 1 .25, 1.5, 1.75, 2.0, and 2.5M sucrose in 0.01Mbis-trislCl pH 6.5, 0.1
mM MgCl 2 . The fraction banding at the 2.0/2 .5 M interface was pelleted at
130,000 g, fixed in glutaraldehyde/NaBH, and reacted with the conjugated
antibodies overnight at 25°C .
RESULTS
Fusion with both cell lines was satisfactory, although the Y3
line was more efficient in this particular comparative experi-
ment (Table 1) . Since considerable variations in fusion effi-
ciency are common, we do not attach much significance to this
individual result. In spite of the difference in fusion efficiency,
the number of cultures which gave positive binding was com-
parable for both experiments.
SDS gel electrophoresis of the secreted Ig chains in fusion
cultures prepared with YB2/O showed that the light chains
often had different mobilities (Fig . 1) . No myeloma light chain
component was detected which would have appeared as a
common light chain band in addition to the various ones
present in Fig . 1 .
The cultures which contained higher antitubulin activity
were cloned, and active clones were recovered between 1 and
2 mo after fusion. At that stage the original cultures were still
positive in all cases, which simplified the recovery of active
clones . Among those clones which grew after picking, the
majority were antitubulin secretors (Table II). The most glaring
exception was YOL1/34, where only 3 out of 18 clones were
positive . The analysis of the immunoglobulin secreted by the
uncloned culture gave as the major component an IgM, while
the cloned product was an IgG antitubulin (Fig. 1) . Clearly,
the culture contained at least two clones and it was not difficult
to isolate the positive one in spite of being a minor component .
The second cloning step gave a very high proportion of posi-
TABLE I
Comparison between Two Rat Myeloma Lines as Parentals for
Hybrid Myelomas
Parental myeloma
* Binding to tubulin-coated plates was three times or more than inactive
supernatants or to uncoated plates .
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tives (Table II) . The results show an overall stability of ex-
pressed chains which was comparable for both sets of fusions .
Characterisation of the Antitubulin
Monoclonal Antibodies
FIGURE 1 Autoradiographs of
the secreted products of hy-
brid myeloma cultures . (a)
10% SDSgel electrophoresis of
selected supernatants from in-
dividual cultures (YOL1/5, 6,
19, 34, and 38) from the YB2/0
fusion prior to cloning and in-
cubated with ['°C] lysine . (b)
7% SDS gel electrophoresis of
similar supernatants from : lane
1 cloned YOL1/34; lane 2
cloned YL1/2 HKL; lane 3 YL1/
2 HK; and lane 4 Y3 . W and y
represent the mobilities of
the immunoglobulin heavy
chains, L the mobility of the
light chains .
The results of the binding of the antitubulin monoclonal
antibodies to yeast and brain tubulin are shown in Table 111.
There are clearly two classes of antibodies, those that bind to
both yeast and chick brain tubuhn, and those that preferentially
bind to yeast tubuhn. Other positive hybrids (not included in
Table 11) were isolated, but their antibodies had anomalous
properties; for example, high binding was observed in the
absence of antigen or they bound to antigens other than
tubulin . One antibody boundwell to tubulin, actin and myosin.
These antibodies were not studied further .
The binding assay for screening used soluble tubulin, so
would select for antibodies binding to most parts of the tubulin
molecule. This type of binding assay was used because it was
the fastest available. However, since one of the proposed uses
of antibodies was purification of microtubule-containing or-
ganelles, it was essential to demonstrate binding to the outside
of the microtubule . To select for such antibodies, we tested
those supernatants which were positives in the binding assay
for their capacity to give immunofluorescent staining of micro-
tubules . Of all the supernatants, only YL1/2 and YOL1/34
gave an unequivocal immunofluorescent staining of both yeast
mitotic spindles and the interphase microtubule network in
CHO and 3T3 cells. Thus, these two clones were selected for
large-scale production of immunoglobulin in rats .
The serum of rats bearing the hybrid myeloma tumourYL 1/
2 orYOL1/34 gave titers in the binding assay ofbetween 1 :10 5
and 1 :106 . Both were purified from the sera, and their DEAE
cellulose chromatographic behavior and SDS gel electropho-
retic analysis of the reduced chains gave results in agreement
with the radioactive experiments (Fig . 1), suggesting that the
antibodies were of the IgG class . A measure of the binding
constant of YL1/2 IgG was obtained by immunoprecipitation
ofMAP-free 1125 brain tubulin (10) using sheep anti-rat IgG as
precipitant at monoclonal antibody concentrations from 80 P.g/
ml to 80 ng/ml . This gave a value for the apparent dissociation
constant of 50 nM, assuming a valency of one for both the
HLK antibody and the antigen. The possibility that this value
is affected by a shift in the equilibrium caused by the binding
of the sheep anti-rat IgG is not excluded.
Indirect immunofluorescence using YL1/2 and YOLI/34
No . of
cells per
culture
No . of
cultures
YB2/O
Growing
cultures
Antitubu-
lin*
Y3/Ag
Growing
cultures
1 .2 .3 .
Antitubu-
lin*
2 X 106 36 34 4 36 4
1 X 106 12 6 1 12 -
0.5X106 12 3 - 12 1
0.25 X 108 36 9 - 20 1Y3 hybrids
Cloning step
￿
YLI/2
￿
YL1/13
￿
YL1/19
￿
YL1/26
First
￿
13/13 6/14 6/6 3/3*
Second 42/48$ - - 8/8
Immunofluorescent staining of yeast
andCHO or 3T3 microtubules
TABLE II
Recovery of Antitubulin Clones
TABLE III
IgGs showed that both stained the interphase network of
microtubules in 3T3 (Fig. 2 a and b) and Chinese hamster
ovary (CHO) cells (data not shown) similarly . However, their
staining of yeast spheroplasts isolated from log phase cells was
slightly different, in thatYL 1/2 IgG gave a diffuse cytoplasmic
staining (Fig . 2 c and d) . Fig . 2 e shows that by lowering the
IgG concentration by a factor of ten the diffuse cytoplasmic
staining of YLI/2 decreases and the spindle staining is now
seen to be similar to YOLI/34 IgG . Although antitubulin
immunofluorescence of yeast cells has not been reported be-
fore, the staining pattern observed with YOL1/34 seems to fit
previous results obtained with the electron microscope (3) .
Mitotic spindles of various length are observed, presumably
depending on what phase ofthe cell cycle the spheroplast was
in . Other microtubules, presumably cytoplasmic, which project
from either end of the spindle, were also observed .
An inactive derivative YL I/2HK was detected as a subclone
during the subcloning of the YLI/2HLK line (Fig . 1). The
spent medium of this line was negative in the binding assay .
The IgG, which retains the antitubulin heavy chain but has its
light chain replaced by the myeloma light chain, was isolated
from serum ascites, and was negative in immunofluorescence
of yeast (Fig . 2f) and tissue culture cells (data not shown) .
There were also differences in indirect immunofluorescent
staining of yeast nuclei by both antibodies (Fig . 3) . During
isolation of the nuclei, most of the spindles break down . Short
microtubules remain attached to the spindle pole bodies which
would stain as a dot by immunofluorescence . YOLI/34 IgG
gives the expected pattern of staining, either a single dot per
nucleus or more rarely a double dot or an occasional complete
spindle (Fig . 3a) . In contrast, YL1/2 IgG gave multiple dot
staining (Fig . 3 b) though when the IgG concentration was
lowered to 0.8 ILg/ml the staining was the same as with YOLI/
34 (data not shown) . The multiple dot staining ofYL1/2 IgG
correlates with the presence of intranuclear tubular complexes
Positive clones/Total tested
Results of Binding Studies
YB2/O hybrids
YOL1/5 YOL1/19 YOL1/23 YOL1/38
6/6 9/10 3/18 9/9
22/23 17/22 12/12 11/11
* One of these became negative 3 wk after first test .
$ Analysis of the secreted material showed that of the six negative clones, three had lost the heavy chain, and three had lost the antibody light chain (e .g., Fig .
1) . Both variants have been kept .
cpm bound by cell supernatants after last cloning step
DISCUSSION
(J. V . Kilmartin and C . Milstein, manuscript in preparation)
previously described by Peterson et al. (27) . When these com-
plexes are removed by preparing crude nuclear envelopes, the
multidot staining disappears and both antibodies now give a
similar pattern of a single or double dot per nuclear ghost .
The specificity of theYL1/2 andYOL1/34 IgGs was further
confirmed in the electron microscope after their conjugation to
-200 A colloidal gold particles (9) and reaction with crude
nuclear envelopes, the conjugated antibodies did not penetrate
intact nuclei . Specific reaction with microtubules attached to
yeast spindle pole bodies is clearly seen (Fig . 4) . This indicates
that the dots seen in the immunofluorescent staining of the
crude nuclear envelopes does represent binding of YOL1/34
and YLI/2 IgG to yeast microtubules attached to the spindle
pole bodies . It is very interesting to note that the size of the
gold particles greatly impairs the ability of the attached anti-
body molecules to penetrate the rightly packed microtubules
close to the spindle pole body.
Both YLI/2 and YOLI/34 monoclonal antibodies seem to
bind the a subunit of tubulin specifically, since they stain that
subunit in pig and partially purified Physarum tubulin after
transfer of the proteins from SDS gels to nitrocellulose sheets
(4) .
Quite apart from the advantages offered by rat x rat fusions in
terms of large-scale production of monoclonal antibody, the
rat myeloma lines which we have used in this paper seem to
possess other valuable properties . The proportion of hybrids
which express spleen immunoglobulin chains is considerably
higher than in mouse x mouse hybrids (5) . It was suggested
that this was due to a higher stability of rat hybrids. The
implication in practical terms, that the rat line was potentially
better than the mouse, is justified by the results presented here .
No problem of loss of cultures before cloning was encountered
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YL1/2
Y3
YL1/13
hybrids
YL1/19 YL1/26 YOL1/5
YB2/O
YOL1/19
hybrids
YOL1/34 YOL1/38
Yeast tubulin 15,000 2,000 2,000 8,000 3,000 1,000 15,000 2,000
Chick brain tubulin 8,000 60 3,000 250 120 1,100 10,000 300
No tubulin 190 60 120 60 120 70 70 120FIGURE 2
￿
Indirect immunofluorescent staining of cells with the monoclonal antitubulin IgG's . 3T3 cells stained with (a) YOt1/34
IgG (30Wg/ml) or (b) Y1.1/2 IgG (70 jAg/ml) . Yeast sphleroplasts stained with (c) YOt1/34 IgG (30 jug/ml), (d) YL1/2 IgG (25 hg/
ml), (e) YL1/2 IgG (2.51rg/mI), and (f) YL1/2 HK IgG (40tLg/m I) . Bar, 10Item . (a) x 1,110 . (b) X 1,270 . (c) X 1,430 . (d) 1,730 . (e) x
1,580 . (f) x 1,630 .
but, instead, a stability, even at early stages, whichwe have not
￿
term experience can give a more reliable picture .
normally observed with mouse fusions . The results are, how-
￿
No significant difference between YB2/O and Y3/Ag 1 .2.3 .
ever, to be taken with caution. They are limited, and only long-
￿
was observed . Perhaps the hybridization efficiency ofYB2/O
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Indirect immunofluorescent staining of yeast nuclei with (a) YOL/34 IgG (30 jug/ml) or (b) YL1/2 IgG (25 ttg/ml) . Bar,
10 pin . (a) x 1,460. (b) x 1,730.
FIGURE 4 Electron micrographs of thin sections of a crude yeast nuclear envelope preparation showing yeast microtubules
attached to spindle pole bodies and labeled with (a) YOL1/34 IgG or (b) YL1/2 IgG conjugated to 200 Á colloidal gold particles .
Bar, 0.1 jim . x 57,000 .
is a little lower than that ofY3/Ag 1.2.3 ., but experience shows
that generally it improves with further use . At any event, the
efficiency was sufficient, and the total number of active clones
was not significantly different . Apart from the absence of a
myeloma light chain, YB2/O has some other advantages over
Y3/Ag 1.2.3 . The cells are slightly larger, more rounded, and
less adherent to the culture vessel . In addition, they are easier
to clone in soft agar because the hybrid clones derived are
tighter, decreasing the risk of cross-contamination with neigh-
boring clones.
We have concentrated our attention on two derivatives,
YL 1/2 andYOL1/34 .When the first fusion wells were assayed,
the binding activity of these two clones was only slightly less
than that observed in Table III after cloning. This was also
found for the other positive hybrids . Thus, if a fusion produces
only weakly positive hybrids, then it may be better to avoid
lengthy cloning attempts, unless some of the clones have par-
ticularly interesting properties . A better investment of time
would be to improve the immunizations and to attempt to
increase the titer of the antisera in other animals followed by
more fusions. Of course, this comment is valid only for cases
like this one when the search is for high affinity antibodies to
a major antigenic component. In other circumstances, a differ-
ent strategy may be more adequate (14) .
The good yield of active clones indicates that immunization
with yeast tubulin may have been a good choice. It is possible
that using yeast tubulin as an antigen is a better way to prepare
antibody to mammalian tubulin, because induction of a strong
immune response could require multiple immunogenic deter-
minants. The antiserum prepared from rats which had tumours
of YL1/2 or YOL1/34 cells had very high titers of between
1 :105 and 1:106, compared to the titer of- 1 :1,000 of the original
antiserum after two tubulin injections. This low titer is slightly
higher than that of most conventional rabbit antitubulin sera
(1, 15, 22) . The purified IgGs ofYL1/2 and YOL1/34 display
overall similar properties to the rabbit monospecific antitubulin
antibodies described to date (2) . For example, they stain the
interphase microtubule network of tissue culture cells at similar
concentrations. YOL1/34 IgG is perhaps more suitable for
general immunofluorescence work, since it gives clear micro-
tubule staining in yeast and tissue culture cells.
The reason for the diffuse cytoplasmic immunofluorescent
staining observed in yeast spheroplasts with YL 1/2 IgG as
compared with YOL1/34 is not clear. It is unlikely to be due
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control and it was observed with glutaraldehyde, formaldehyde
and methanol fixation. It is possible that in yeast spheroplasts
there are different forms of tubulin antigens, and the equilib-
rium constant of YL1/2 and YOL1/34 for the structural var-
iants are different . Diffuse cytoplasmic staining with monospe-
cific antitubulin has also been observed in Dictyostelium (32) .
Whatever the reason, this difference as well as the multidot
staining of nuclei (Fig. 3 b) given by the different monoclonal
antibodies is a likely long-term asset for many purposes . It
remains to be seen whether for general use specific mixtures to
mimic polyclonal reagents will be more convenient or better
than selected monoclonal antibodies.
We are currently investigating the potential of these mono-
clonal antibodies in purifying microtubule-containing organ-
elles, particularly in yeast spindle pole bodies with half-spindles
attached, using the methods developed by Ito and Palade (17)
with conventional antisera.
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